A late-stage trial for a potential Covid-19 vaccine being developed by Oxford University and AstraZeneca (AZN) has been paused, due to a possible serious adverse reaction in a participant. Health publication Stat News, which first reported the update on Tuesday evening, said that the participant in question was based in the UK and is expected to recover.
IC TIP:
Buy
at
8222p